Treatment of migraine: update on new therapies
Author:
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Neurology (clinical),Neurology
Reference56 articles.
1. Cost of disorders of the brain in Europe;Andlin-Sobocki;Eur J Neurol,2005
2. Excellent tolerability but relatively low initial clinical efficacy of telcagepant in migraine.;Tfelt-Hansen;Headache,2011
3. Triptans (serotonin, 5-HT1B/1D agonists) in migraine: detailed results and methods of a meta-analysis of 53 trials;Ferrari;Cephalalgia,2002
4. Randomized, controlled trial of telcagepant over four migraine attacks;Ho;Cephalalgia,2010
5. Efficacy and tolerability of MK-0974 (telcagepant), a new oral antagonist of calcitonin gene-related peptide receptor, compared with zolmitriptan for acute migraine: a randomised, placebo-controlled, parallel-treatment trial;Ho;Lancet,2008
Cited by 36 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Efficacy and safety of levetiracetam for migraine prophylaxis in children: a systematic review and meta-analysis;Frontiers in Pharmacology;2024-08-06
2. Role of Antioxidants in the Management of Migraine Pain;Management of Migraine Pain;2024
3. Comparing Prophylactic Effect of Levetiracetam, Sodium Valproate, and Propranolol in Pediatric Migraine: A Randomized Clinical Trial;IRAN J CHILD NEUROL;2023
4. Neurological diseases: Sex and gender evidence in stroke, migraine, and Alzheimer’s dementia;How Sex and Gender Impact Clinical Practice;2021
5. Recent Advances in Migraine Therapy;Migraine;2020-12-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3